Canine and Feline Epilepsy. Luisa De Risio
Читать онлайн книгу.
Pakozdy, A., Halasz, P., Klang, A., Bauer, J., Leschnik, M., Tichy, A., Thalhammer, J.G., Lang, B. and Vincent, A. (2013) Suspected Limbic Encephalitis and Seizure in Cats Associated with Voltage-Gated Potassium Channel (VGKC) Complex Antibody. Journal of Veterinary Internal Medicine 27, 212–214.
Pardridge, W.M. (1999) Blood-brain barrier biology and methodology. Journal of Neurovirology 5, 556–569.
Pekcec, A., Unkruer, B., Schlichtiger, J., Soerensen, J., Hartz, A.M., Bauer, B., van Vliet, E.A., Gorter, J.A. and Potschka, H. (2009a) Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation. The Journal of Pharmacology and Experimental Therapeutics 330, 939–947.
Pekcec, A., Unkruer, B., Stein, V., Bankstahl, J.P., Soerensen, J., Tipold, A., Baumgartner, W. and Potschka, H. (2009b) Over-expression of P-glycoprotein in the canine brain following spontaneous status epilepticus. Epilepsy Research 83, 144–151.
Penning, V.A., Connolly, D.J., Gajanayake, I., McMahon, L.A., Luis Fuentes, V., Chandler, K.E. and Volk, H.A. (2009) Seizure-like episodes in 3 cats with intermittent high-grade atrioventricular dysfunction. Journal of Veterinary Internal Medicine 23, 200–205.
Picot, M.C., Baldy-Moulinier, M., Daures, J.P., Dujols, P. and Crespel, A. (2008) The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia 49, 1230–1238.
Placencia, M., Sander, J.W., Shorvon, S.D., Roman, M., Alarcon, F., Bimos, C. and Cascante, S. (1993) Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Research 14, 237–244.
Platt, S.R., Adams, V., Garosi, L.S., Abramson, C.J., Penderis, J., De Stefani, A. and Matiasek, L. (2006) Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Veterinary Record 159, 881–884.
Podell, M. and Fenner, W.R. (1993) Bromide therapy in refractory canine idiopathic epilepsy. Journal of Veterinary Internal Medicine 7, 318–327.
Potschka, H. (2010) Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies? Epilepsia 51, 1333–1347.
Potschka, H. (2012) Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport. Advanced Drug Delivery Reviews 64, 943–952.
Potschka, H., Fedrowitz, M. and Löscher, W. (2002) P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neuroscience Letters 327, 173–176.
Potschka, H., Volk, H.A. and Löscher, W. (2004) Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats. Neuroreport 15, 1657–1661.
Rao, V.V., Dahlheimer, J.L., Bardgett, M.E., Snyder, A.Z., Finch, R.A., Sartorelli, A.C. and Piwnica-Worms, D. (1999) Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proceedings of the National Academy 96, 3900–3905.
Regesta, G. and Tanganelli, P. (1999) Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Research 34, 109–122.
Remy, S., Gabriel, S., Urban, B.W., Dietrich, D., Lehmann, T.N., Elger, C.E., Heinemann, U. and Beck, H. (2003) A novel mechanism underlying drug resistance in chronic epilepsy. Annals of Neurology 53, 469–479.
Sander, J.W. and Shorvon, S.D. (1996) Epidemiology of the epilepsies. Journal of Neurology, Neurosurgery, and Psychiatry 61, 433–443.
Schinkel, A.H., Smit, J.J., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van Deemter, L., Mol, C.A., van der Valk, M.A., Robanus-Maandag, E.C. and te Riele, H.P. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491–502.
Schinkel, A.H., Wagenaar, E., Mol, C.A. and van Deemter, L. (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. Journal of Clinical Investigation 97, 2517–2524.
Schmied, O., Scharf, G., Hilbe, M., Michal, U., Tomsa, K. and Steffen, F. (2008) Magnetic resonance imaging of feline hippocampal necrosis. Veterinary Radiology and Ultrasound 49, 343–349.
Schrickx, J.A. and Fink-Gremmels, J. (2008) Implications of ABC transporters on the disposition of typical veterinary medicinal products. European Journal of Pharmacology 585, 510–519.
Schwartz-Porsche, D. (1986) Epidemiological, clinical and pharmacokinetic studies in spontaneously epileptic dogs and cats. Proceedings of the American College of Veterinary Internal Medicine, pp. 1161–1163.
Schwartz-Porsche, D., Löscher, W. and Frey, H.H. (1985) Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. Journal of Veterinary Pharmacology and Therapeutics 8, 113–119.
Seppala, E.H., Jokinen, T.S., Fukata, M., Fukata, Y., Webster, M.T., Karlsson, E.K., Kilpinen, S.K., Steffen, F., Dietschi, E., Leeb, T., Eklund, R., Zhao, X., Rilstone, J.J., Lindblad-Toh, K., Minassian, B.A. and Lohi, H. (2011) LGI2 truncation causes a remitting focal epilepsy in dogs. PLoS Genetics 7, e1002194.
Shihab, N., Bowen, J. and Volk, H.A. (2011) Behavioral changes in dogs associated with the development of idiopathic epilepsy. Epilepsy and Behavior 21, 160–167.
Shukla, S.J., Sakamuru, S., Huang, R., Moeller, T.A., Shinn, P., Vanleer, D., Auld, D.S., Austin, C.P. and Xia, M. (2011) Identification of clinically used drugs that activate pregnane X receptors. Drug Metabolism and Disposition: the Biological Fate of Chemicals 39, 151–159.
Sisodiya, S.M., Lin, W.R., Harding, B.N., Squier, M.V. and Thom, M. (2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125, 22–31.
Spector, R. (2000) Drug transport in the mammalian central nervous system: multiple complex systems. A critical analysis and commentary. Pharmacology 60, 58–73.
Tishler, D.M., Weinberg, K.I., Hinton, D.R., Barbaro, N., Annett, G.M. and Raffel, C. (1995) MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36, 1–6.
Trepanier, L.A., Van Schoick, A., Schwark, W.S. and Carrillo, J. (1998) Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996). Journal of the American Veterinary Medical Association 213, 1449–1453.
Vincent, A., Irani, S.R. and Lang, B. (2010) The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Current Opinion in Neurology 23, 144–150.
Volk, H.A. and Löscher, W. (2005) Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 128, 1358–1368.
Volk, H.A., Burkhardt, K., Potschka, H., Chen, J., Becker, A. and Löscher, W. (2004a) Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures. Neuroscience 123, 751–759.
Volk, H.A., Potschka, H. and Löscher, W. (2004b) Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats. Epilepsy Research 58, 67–79.
Volk, H.A., Arabadzisz, D., Fritschy, J.M., Brandt, C., Bethmann, K. and Löscher, W. (2006) Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABA(A) receptor ligand binding in a model of temporal lobe epilepsy. Neurobiology of Disease 21, 633–646.
Volk, H.A., Matiasek, L.A., Luján Feliu-Pascual, A., Platt, S.R. and Chandler, K.E. (2008)